Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes

Frontiers in Endocrinology(2021)10.3389/fendo.2020.600439Source: DataRank Database

Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes is a research paper published in Frontiers in Endocrinology (2021). On theSindex it has a DataRank of 0. It has been cited 177 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access177 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: goldTopics (32)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Tiffany Grimes,Peng Li ORCID,Matthew Might ORCID,Fernando Ovalle ORCID,Anath Shalev ORCID

Live enrichment

PubMed:19910364 OpenAlex:https://openalex.org/W33519709

National Institutes of Health

Grant: R01DK078752, U01DK120379, UL1TR001417

National Institutes of Health

Grant: 3UL1TR001417-01S1

UAB Center for Clinical and Translational Science (CCTS)

National Institutes of Health

Grant: 2R01DK078752-07A1

TXNIP Regulation of Endogenous Beta Cell Mass

National Institutes of Health

Grant: 5K04DK002019-02

MECHANISMS IN THE REGULATION OF PROLACTIN SECRETION

National Institutes of Health

Grant: 1U01DK120379-01

Development of an early diagnostic biomarker and novel treatment strategy for T1D

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fendo.2020.600439/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fendo.2020.600439/full

journalhttps://dialnet.unirioja.es/servlet/articulo?codigo=2180528

repositoryhttps://doaj.org/article/3270eafd83924ee7a01f123768c8c5f9

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7838490

Fields of Study

Global Trade and Competitiveness0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

GeographyMedicineMaleDiseases of the endocrine glands. Clinical endocrinologyEndocrinologyDiabetes MellitusEthnicityHumansHypoglycemic AgentsHospital MortalityAgedRetrospective StudiesAfrican-AmericandiabetesSARS-CoV-2coronavirus disease-2019COVID-19Middle AgedRC648-665PrognosismortalityMetforminUnited StatesCOVID-19 Drug TreatmentHospitalizationSurvival RateFemaleFollow-Up Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Life below water